Sakar Healthcare (SAKAR) | Stock Overview & Key Data

Sakar Healthcare Ltd. | Small-cap | Healthcare

₹363.20

1.55%

Sakar Healthcare vs Sun Pharmaceutical Sakar Healthcare vs Divi's Laboratories Sakar Healthcare vs Innova Captab Sakar Healthcare vs Suven Life Sciences Sakar Healthcare vs Gujarat Themis Sakar Healthcare vs NIFTY 50 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Sakar Healthcare Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Sakar Healthcare	Healthcare Sector	NIFTY 50
1 Week	1.55%	N/A	N/A
1 Month	8.59%	N/A	N/A
3 Months	3.85%	N/A	N/A
6 Months	51.52%	N/A	N/A
1 Year	14.89%	N/A	N/A
3 Years	24.94%	N/A	N/A
5 Years	528.56%	N/A	N/A

Stock Range

Today's Range

Low: ₹353.00 High: ₹368.40

on October 7, 2025

52 Week Range

Low: ₹210.10 High: ₹380.80

on March 28, 2025

on June 19, 2025

All-Time High: ₹479.00 on January 22, 2024

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR8.2B

EPS i 9.03

P/E Ratio (TTM) i 40.14

Forward P/E i N/A

P/B Ratio i 2.75

PEG Ratio i 0.44

Div. Yield i N/A

ROE i 6.13%

Beta i 0.044

Debt to Equity i 30.26

Financial Highlights

Profitability

Gross Margin i 45.10%

Operating Margin i 13.53%

Profit Margin i 10.45%

Returns and Earnings

Return on Assets (TTM) i 4.21%

Return on Equity (TTM) i 6.13%

EBITDA i INR523.0M

Net Income (TTM) i INR197.6M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i INR86.18

Quarterly Revenue Growth (YoY) i 28.20%

Quarterly Earnings Growth (YoY) i 93.70%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Sakar Healthcare SAKAR	8.18B Small-cap	1.55%	8.59%	3.85%	51.52%	18.58%	14.89%	24.94%	528.56%
Sun Pharmaceutical SUNPHARMA	4.01T Large-cap	4.12%	4.66%	-1.50%	-0.70%	-12.45%	-13.00%	69.49%	239.84%
Divi's Laboratories DIVISLAB	1.61T Large-cap	2.26%	-3.33%	-15.42%	10.79%	-4.06%	-5.14%	63.08%	80.80%
Innova Captab INNOVACAP	48.64B Small-cap	0.46%	-4.62%	-2.11%	-0.23%	-24.99%	16.46%	53.72%	53.72%
Suven Life Sciences SUVEN	47.99B Small-cap	3.79%	-10.27%	-21.82%	76.25%	63.70%	49.21%	215.69%	329.98%
Gujarat Themis GUJTHEM	46.19B Small-cap	5.81%	11.73%	24.24%	72.58%	76.09%	95.83%	95.83%	95.83%

Ownership & Short Interest

Insider Ownership i N/A

Institutional Ownership i N/A

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 22K

Average 90-Day Volume i 17K

Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of , please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: 1.55%
1 Month: 8.59%
3 Months: 3.85%
1 Year: 14.89%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is SAKAR's 52-week high and low?

In the last 52 weeks, Sakar Healthcare reached a high of ₹380.80 (on June 19, 2025) and a low of ₹210.10 (on March 28, 2025).

What is the market cap and P/E ratio for SAKAR?

Curious about Sakar Healthcare's size and valuation? Its market capitalization stands at 8.18B. When it comes to valuation, the P/E ratio (trailing twelve months) is 40.14, and the forward P/E (looking ahead) is N/A.

Does SAKAR pay dividends? If so, what's the yield?

As for dividends, Sakar Healthcare isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Sakar Healthcare's main competitors or similar companies to consider before investing?

When looking at Sakar Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Sun Pharmaceutical SUNPHARMA	4.01T	Healthcare	Drug Manufacturers - Specialty & Generic	-13.00%	69.49%
Divi's Laboratories DIVISLAB	1.61T	Healthcare	Drug Manufacturers - Specialty & Generic	-5.14%	63.08%
Innova Captab INNOVACAP	48.64B	Healthcare	Drug Manufacturers - Specialty & Generic	16.46%	53.72%
Suven Life Sciences SUVEN	47.99B	Healthcare	Drug Manufacturers - Specialty & Generic	49.21%	215.69%
Gujarat Themis GUJTHEM	46.19B	Healthcare	Drug Manufacturers - Specialty & Generic	95.83%	95.83%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Sakar Healthcare Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Sakar Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.13%, the Debt to Equity ratio from the most recent quarter is 30.26, and its Gross Profit Margin stands at 45.10%.

What is the recent revenue and earnings growth for SAKAR?

Looking at Sakar Healthcare's growth, its revenue over the trailing twelve months (TTM) was INR2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 28.20%, and quarterly earnings saw a YoY growth of 93.70%.

How much of SAKAR stock is held by insiders and institutions?

Wondering who owns Sakar Healthcare stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.